EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Parallel DNA/RNA NGS Using an Identical Target Enrichment Panel in the Analysis of Hereditary Cancer Predisposition

Petra Kleiblová, Marta Černá, Petra Zemánková, Kateřina Matějková, Petr Nehasil, Jan Hojný, Klára Horáčková, Markéta Janatová, Jana Soukupová, Barbora Šťastná, Zdeněk Kleibl

Folia Biologica · 2024

DOI: 10.14712/fb2024070010062 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Folia Biologica, 2024. Verfasst von Petra Kleiblová und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Rep…. Hauptthemen laut MEDLINE: Genetic Predisposition to Disease, High-Throughput Nucleotide Sequencing. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerstvo Zdravotnictví Ceské Republiky, Univerzita Karlova v Praze, Ministerstvo Školství, Mládeže a Tělovýchovy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Germline DNA testing using the next-gene­ration sequencing (NGS) technology has become the analytical standard for the diagnostics of hereditary diseases, including cancer. Its increasing use places high demands on correct sample identification, independent confirmation of prioritized variants, and their functional and clinical interpretation. To streamline these processes, we introduced parallel DNA and RNA capture-based NGS using identical capture panel CZECANCA, which is routinely used for DNA analysis of hereditary cancer predisposition. Here, we present the analytical workflow for RNA sample processing and its analytical and diagnostic performance. Parallel DNA/RNA analysis allowed credible sample identification by calculating the kinship coefficient. The RNA capture-based approach enriched transcriptional targets for the majority of clinically relevant cancer predisposition genes to a degree that allowed analysis of the effect of identified DNA variants on mRNA processing. By comparing the panel and whole-exome RNA enrichment, we demonstrated that the tissue-specific gene expression pattern is independent of the capture panel. Moreover, technical replicates confirmed high reproducibility of the tested RNA analysis. We concluded that parallel DNA/RNA NGS using the identical gene panel is a robust and cost-effective diagnostic strategy. In our setting, it allows routine analysis of 48 DNA/RNA pairs using NextSeq 500/550 Mid Output Kit v2.5 (150 cycles) in a single run with sufficient coverage to analyse 226 cancer predisposition and candidate ge­nes. This approach can replace laborious Sanger confirmatory sequencing, increase testing turnaround, reduce analysis costs, and improve interpretation of the impact of variants by analysing their effect on mRNA processing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic Predisposition to DiseaseHigh-Throughput Nucleotide SequencingHumansNeoplasmsRNAReproducibility of ResultsSequence Analysis, DNASequence Analysis, RNADNA

Stichwörter der Autor:innen

ATMBRCA1BRCA2CHEK2CZECANCADNANGSRNATSC2aberrant splicingalternative splicingdeep intronic variantgene expressiongermline genetic testinghereditary cancer predisposition

Substanzen

RNADNA

Autor:innen und Institutionen

  • Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic. pekleje@lf1.cuni.cz.
  • Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic. pekleje@lf1.cuni.cz.
  • Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
  • Institute of Pathological Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Department of Genetics and Microbiology, Faculty of Science, Charles University, Prague, Czech Republic.
  • Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.

Förderung

  • Ministerstvo Zdravotnictví Ceské Republiky
  • Univerzita Karlova v Praze
  • Ministerstvo Školství, Mládeže a Tělovýchovy

Zitieren

APA

Kleiblová, P., Černá, M., Zemánková, P., Matějková, K., Nehasil, P., Hojný, J., Horáčková, K., Janatová, M., Soukupová, J., Šťastná, B., & Kleibl, Z. (2024). Parallel DNA/RNA NGS Using an Identical Target Enrichment Panel in the Analysis of Hereditary Cancer Predisposition. Folia Biologica. https://doi.org/10.14712/fb2024070010062

Vancouver

Kleiblová P, Černá M, Zemánková P, Matějková K, Nehasil P, Hojný J, et al. Parallel DNA/RNA NGS Using an Identical Target Enrichment Panel in the Analysis of Hereditary Cancer Predisposition. Folia Biologica. 2024. doi:10.14712/fb2024070010062

BibTeX
@article{Kleiblov2024,
  author = {Kleiblová, Petra and Černá, Marta and Zemánková, Petra and Matějková, Kateřina and Nehasil, Petr and Hojný, Jan and Horáčková, Klára and Janatová, Markéta and Soukupová, Jana and Šťastná, Barbora and Kleibl, Zdeněk},
  title = {Parallel DNA/RNA NGS Using an Identical Target Enrichment Panel in the Analysis of Hereditary Cancer Predisposition},
  journal = {Folia Biologica},
  year = {2024},
  doi = {10.14712/fb2024070010062}
}
Kostenlos starten →